Neutrophil gelatinase-associated lipocalin and its receptors in Alzheimer’s disease (AD) brain regions: differential findings in AD with and without depression

Manuscript Number: 

16-0330R1

Author(s): 
Peter P. De Deyn, Doortje W. Dekens, Ulrich L.M. Eisel, Sebastiaan Engelborghs, Petrus J.W. Naude, Richard C. Oude Voshaar, Debby Van Dam, Yannick Vermeiren

Disclosures

Peter P. De Deyn

  • Consulting Fees:
    from Johnson & Johnson and from Sotio

Doortje W. Dekens

  • Nothing to Disclose

Ulrich L.M. Eisel

  • Nothing to Disclose

Sebastiaan Engelborghs

  • Consulting Fees:
    Innogenetics / Fujirebio Europe, Lundbeck, Pfizer, Novartis, UCB, Roche diagnostics, Nutricia / Danone, Eli Lilly
    Grants
    • Agency: 
      Janssen Pharmaceutica NV and ADx Neurosciences
      Dates: 
      1 OCT 2015 - ONG

Petrus J.W. Naude

  • Nothing to Disclose

Richard C. Oude Voshaar

  • Nothing to Disclose

Debby Van Dam

  • Nothing to Disclose

Yannick Vermeiren

  • Nothing to Disclose